ACADIA Pharmaceuticals Names New Board Member

San Diego-based ACADIA Pharmaceuticals, which is developing biopharmaceuticals for treating central nervous system disorders, aid today that it has named Daniel Soland to its board of directors. Soland was perviously Senior Vice President and COO of ViroPharma, and alsos previously was at Chiron Corporation, Epigensis Pharmaceuticals, and GlaxoSmithKline. Soland currently sits on the boards of Tarsa Therapeutics and DBV Technologies SA.